Patents by Inventor Roxanne L. Richman
Roxanne L. Richman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6645202Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.Type: GrantFiled: October 27, 2000Date of Patent: November 11, 2003Assignee: Epicor Medical, Inc.Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
-
Publication number: 20030079753Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: ApplicationFiled: August 30, 2002Publication date: May 1, 2003Applicant: EPICOR, INC.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
-
Publication number: 20030069574Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: December 5, 2001Publication date: April 10, 2003Applicant: Epicor, Inc.Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Publication number: 20030069577Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: ApplicationFiled: August 30, 2002Publication date: April 10, 2003Applicant: EPICOR, INC.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
-
Publication number: 20030028187Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: ApplicationFiled: June 12, 2002Publication date: February 6, 2003Applicant: Epicor, Inc.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
-
Patent number: 6484727Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: GrantFiled: November 15, 1999Date of Patent: November 26, 2002Assignee: Epicor, Inc.Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
-
Patent number: 6474340Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: GrantFiled: November 15, 1999Date of Patent: November 5, 2002Assignee: Epicor, Inc.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
-
Publication number: 20020128639Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.Type: ApplicationFiled: December 21, 2001Publication date: September 12, 2002Applicant: EPICOR, INC., a Delaware CorporationInventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad
-
Publication number: 20020087157Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: December 5, 2001Publication date: July 4, 2002Applicant: Epicor, Inc.Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Publication number: 20020072741Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: June 19, 2001Publication date: June 13, 2002Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Publication number: 20020045895Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: December 5, 2001Publication date: April 18, 2002Applicant: Epicor, Inc.Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Publication number: 20020042611Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: December 5, 2001Publication date: April 11, 2002Applicant: Epicor, Inc.Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Publication number: 20020042610Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.Type: ApplicationFiled: December 5, 2001Publication date: April 11, 2002Applicant: Epicor, Inc.Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
-
Patent number: 6314962Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: GrantFiled: November 15, 1999Date of Patent: November 13, 2001Assignee: Epicor, Inc.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
-
Patent number: 6314963Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: GrantFiled: November 15, 1999Date of Patent: November 13, 2001Assignee: Epicor, Inc.Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
-
Patent number: 6311692Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.Type: GrantFiled: July 19, 1999Date of Patent: November 6, 2001Assignee: Epicor, Inc.Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
-
Patent number: 5562720Abstract: An endometrial ablation device and a method of manufacturing and using the device. An RF current is passed through an endometrium to heat it. An electroconductive expandable member such as a balloon is used as the medium for passing the current and causing the heating of the endometrium. The power delivered from a power source to the balloon is selectively provided to a plurality of electrode area segments on the balloon with each of the segments have a thermistor associated with it whereby temperature is monitored and controlled by a feedback arrangement from the thermistors. The selective application of power is provided on the basis of a switching arrangement which provides either monopolar or bipolar energy to the electrodes. The method of manufacturing the ablation device includes using commercially available stretchable sheet material or providing a mandrel or support base and coating the mandrel or base with an uncured emulsion. The emulsion is then cured to form a bladder-like coating.Type: GrantFiled: October 6, 1994Date of Patent: October 8, 1996Assignee: Vesta Medical, Inc.Inventors: Roger A. Stern, Vincent N. Sullivan, Roxanne L. Richman, Loren L. Roy, Robert L. Marion, Thomas D. Striegler